NYSEMKT: CANF
Can Fite Biopharma Ltd Stock Forecast, Predictions & Price Target

Analyst price target for CANF

Based on 2 analysts offering 12 month price targets for Can Fite Biopharma Ltd

Min Forecast
$7.00+369.8%
Avg Forecast
$7.50+403.36%
Max Forecast
$8.00+436.91%

Should I buy or sell CANF stock?

Based on 2 analysts offering ratings for Can Fite Biopharma Ltd.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CANF stock forecasts and price targets.

CANF stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-07-02
lockedlocked$00.00+00.00%2026-05-13

1 of 1

CANF vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CANF$1.49$7.50+403.36%Strong Buy
DRMA$0.66N/AN/A
SILO$1.91N/AN/A
ERNA$1.79N/AN/A
PPBT$1.56$17.00+989.74%Buy

Can Fite Biopharma Stock Forecast FAQ

Is Can Fite Biopharma Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NYSEMKT: CANF) stock is to Strong Buy CANF stock.

Out of 2 analysts, 1 (50%) are recommending CANF as a Strong Buy, 1 (50%) are recommending CANF as a Buy, 0 (0%) are recommending CANF as a Hold, 0 (0%) are recommending CANF as a Sell, and 0 (0%) are recommending CANF as a Strong Sell.

If you're new to stock investing, here's how to buy Can Fite Biopharma stock.

What is CANF's Price Target?

According to 2 Wall Street analysts that have issued a 1 year CANF price target, the average CANF price target is $7.50, with the highest CANF stock price forecast at $8.00 and the lowest CANF stock price forecast at $7.00.

On average, Wall Street analysts predict that Can Fite Biopharma's share price could reach $7.50 by Jul 2, 2027. The average Can Fite Biopharma stock price prediction forecasts a potential upside of 403.36% from the current CANF share price of $1.49.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.